Wide variation and patterns of physicians' responses to drug-drug interaction alerts

被引:11
|
作者
Cho, Insook [1 ,2 ,3 ]
Lee, Yura [4 ]
Lee, Jae-Ho [4 ,5 ]
Bates, David W. [2 ,3 ,6 ]
机构
[1] Inha Univ, Dept Nursing, Incheon 22212, South Korea
[2] Brigham & Womens Hosp, Div Gen Internal Med, Ctr Patient Safety Res & Practice, 75 Francis St, Boston, MA 02115 USA
[3] Harvard Med Sch, Boston, MA 02115 USA
[4] Asan Med Ctr, Dept Biomed Informat, Seoul, South Korea
[5] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Emergency Med, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea
[6] Partners Healthcare Syst, Wellesley, MA 02481 USA
基金
美国医疗保健研究与质量局;
关键词
computerized physician order entry; drug-drug interaction; alert override; behavior pattern; variation analysis; BEHAVIOR; OVERRIDE;
D O I
10.1093/intqhc/mzy102
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objectives Providing physicians with alerts about potentially harmful drug-drug interactions (DDIs) is only moderately effective due to high alert override rates. To understand high override behavior on DDI alerts, we investigated how physicians respond to DDIs and their behavior patterns and variations. Design Retrospective system log data analysis and records review (sampling 2% of total overrides). Setting A large tertiary academic hospital. Participants About 560 physicians and their override responses to DDI alerts generated from 1 September to 31 December 2014. Interventions Not applicable. Main Outcome Measure(s) DDI alert frequency and override rate. Results We found significant variation in both the number of alerts and override rates at the levels of physicians, departments and drug-class pairs. Physician-level variations were wider for residents than for faculty staff (number of alerts: t = 254.17, P = 0.011; override rates: t = -4.77, P < 0.0001). Using the number of alerts and their override rate, we classified physicians into four groups: inexperienced incautious users, inexperienced cautious users, experienced cautious users and experienced incautious users. Medical department influenced both alert numbers and override rates. Nearly 90% of the overrides involved only five drug-class combinations, which had a wide range of appropriateness in the chart review. Conclusion The variations at drug-class levels suggest issues with system design and the DDI rules. Department-level variation may be best addressed at the department level, and the rest of the variation appears related to individual physician responses, suggesting the need for interventions at an individual level.
引用
收藏
页码:89 / 95
页数:7
相关论文
共 50 条
  • [41] Understanding the Drug-Drug Interaction
    Yim, Dong-Seok
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2006, 49 (01): : 78 - 85
  • [42] The Impact of Customized Screening Intervals on the Burden of Drug-Drug Interaction Alerts: An Interrupted Time Series Analysis
    Van de Sijpe, Greet
    Walgraeve, Karolien
    Van Laer, Eva
    Quintens, Charlotte
    Machiels, Christophe
    Foulon, Veerle
    Casteels, Minne
    Van der Linden, Lorenz
    Spriet, Isabel
    JOURNAL OF MEDICAL SYSTEMS, 2024, 48 (01)
  • [43] Reduced Effectiveness of Interruptive Drug-Drug Interaction Alerts after Conversion to a Commercial Electronic Health Record
    Adam Wright
    Skye Aaron
    Diane L. Seger
    Lipika Samal
    Gordon D. Schiff
    David W. Bates
    Journal of General Internal Medicine, 2018, 33 : 1868 - 1876
  • [44] User-centered design improves the usability of drug-drug interaction alerts: Experimental comparison of interfaces
    Luna, Daniel R.
    Rizzato Lede, Daniel A.
    Otero, Carlos M.
    Risk, Marcelo R.
    Bernaldo de Quiros, Fernan Gonzalez
    JOURNAL OF BIOMEDICAL INFORMATICS, 2017, 66 : 204 - 213
  • [45] Think time: A novel approach to analysis of clinicians' behavior after reduction of drug-drug interaction alerts
    Schreiber, Richard
    Gregoire, Julia A.
    Shaha, Jacob E.
    Shaha, Steven H.
    INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS, 2017, 97 : 59 - 67
  • [46] Clinically relevant QTc prolongation due to overridden drug-drug interaction alerts: a retrospective cohort study
    van der Sijs, Heleen
    Kowlesar, Ravi
    Klootwijk, A. Peter J.
    Nelwan, Stefan P.
    Vulto, Arnold G.
    van Gelder, Teun
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 67 (03) : 347 - 354
  • [47] Reduced Effectiveness of Interruptive Drug-Drug Interaction Alerts after Conversion to a Commercial Electronic Health Record
    Wright, Adam
    Aaron, Skye
    Seger, Diane L.
    Samal, Lipika
    Schiff, Gordon D.
    Bates, David W.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2018, 33 (11) : 1868 - 1876
  • [48] Drug Repurposing Based on Drug-Drug Interaction
    Zhou, Bin
    Wang, Rong
    Wu, Ping
    Kong, De-Xin
    CHEMICAL BIOLOGY & DRUG DESIGN, 2015, 85 (02) : 137 - 144
  • [49] Six patterns of drug-drug interactions
    Armstrong, SC
    Cozza, KL
    Sandson, NB
    PSYCHOSOMATICS, 2003, 44 (03) : 255 - 258
  • [50] Impact of Specific Alerts in Potassium-Increasing Drug-Drug Interactions
    Eschmann, Emmanuel
    Beeler, Patrick E.
    Blaser, Juerg
    MEDINFO 2015: EHEALTH-ENABLED HEALTH, 2015, 216 : 949 - 949